GlaxoSmithKline

There are a number of vaccine programmes which have advanced to stage three trials, the final hurdle before approval, including

Glaxosmithkline (GSK) saw profit attributable to shareholders slip nearly a fifth in the third quarter, but said it was on

Glaxosmithkline (GSK) has today announced that it is beginning human trials of the coronavirus vaccine it is developing with French

Revenue at drugs giant Glaxosmithkline (GSK) fell below analyst expectations today as sales of its blockbuster Shingles vaccine contracted sharply

Drug giant Glaxosmithkline (GSK) today announced that it would aim to produce 1bn vaccine booster shots next year in a

Pharmaceuticals giant Glaxosmithkline (GSK) beat analysts’ expectations with its first quarter results today, and said it remained on course to

The chief executive of pharmaceuticals giant Glaxosmithkline (GSK) has urged companies to join together to speed the development of a

Pharmaceuticals giant Glaxosmithkline (GSK) has joined forces with French drugmaker Sanofi to develop a vaccine for the coronavirus disease. The

Pharmaceuticals giant Glaxosmithkline (GSK) has taken a $250m (£202.7m) stake in an American biotech company in a collaborative effort to

Consumer goods giant Unilever has today completed the acquisition of Horlicks and other Glaxosmithkline brands in a £397m deal. The

Multinational drug firm Glaxosmithkline (GSK) saw a small rise in operating profit and earnings in 2019 as the firm announced

Glaxosmithkline have reported group sales of £9.4bn for the third quarter, with total operating profits of £2.1m, compared with £1.9m